Lena Jendeberg

Director/Board Member at ATTANA AB

60 year

Health Technology

Health Services

Consumer Services

Lena Jendeberg active positions

Companies	Position	Start	End
ATTANA AB	Director/Board Member	2017-12-31	-

Companies	Position	Start	End
Modus Therapeutics AB Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden.	Corporate Officer/Principal	2015-12-31	-

Royal Institute of Technology

Doctorate Degree

International

Sweden

Operational

Corporate Officer/Principal	1
Director/Board Member	1
Doctorate Degree	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
ATTANA AB	Health Services

Private companies	1
Modus Therapeutics AB Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden.	Health Technology

Private companies

Health Technology